Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Sponsor: InSightec
Summary
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
Key Details
Gender
All
Age Range
30 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2023-01-23
Completion Date
2029-07-31
Last Updated
2026-03-20
Healthy Volunteers
No
Interventions
Exablate Pallidotomy, Unilateral
Unilateral pallidotomy using focused ultrasound for the treatment of Parkinson's Disease with medication-refractory moderate to severe motor complications.
Locations (5)
University of Maryland, Baltimore
Baltimore, Maryland, United States
Weill Cornell Medicine
New York, New York, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Ohnishi Neurological Center
Akashi, Hyōgo, Japan